In 50 intact white rats at the age of 6, 15, 23 and 30 months synapsoarchitectonics of the celiac plexus nodes was studied by an electron microscopy method. Peculiarities in synapsoarchitectonics are stipulated by pericaryon processes in neurons, some of them have no contacts with the axonal terminals, while others have contacts with the axonal terminals. The former include small (about 0.5 mkm) drop-like and large (up to 1.5 mkm) polymorphous processes within the limits of perisomatic membrane, as well as processes penetrating the neuronal capsule. All of them contain, in different combinations, vesicles, ribosomas, fibrillae, and the largest processes--small cisterns of granular cytoplasmatic network and single mitochondria. The processes of the first group are considered as original stages for the development of the second group processes. The latter are represented by different in size (about 1.0--2.0 mkm) in form (digital, cone-, pin-, goblet-shaped, cylindrical, branching) and in content formations. There is, as a rule, one contact on the processes of an uncomplicated form, while on the branching processes there can be up to three and more contacting axonal terminals. Peculiar features in the composition of the processes taken as a whole (specific forms, absence of dendritic tubes, sometimes numerous contacts with axonal terminals in spite of small size) distinguish them from newly forming dendritic processes and these formations are considered as independent specialized receptor apparatus in the pericaryon of neurons of the celiac plexus.
Download full-text PDF |
Source |
---|
Neurol Neuroimmunol Neuroinflamm
March 2025
Institute for Clinical Neurobiology, University Hospital, Julius-Maximilians-University of Würzburg, Germany.
Background And Objectives: Autoantibodies (aAbs) against glycine receptors (GlyRs) are mainly associated with the rare neurologic diseases stiff person syndrome (SPS) and progressive encephalomyelitis with rigidity and myoclonus (PERM). GlyR aAbs are also found in other neurologic diseases such as epilepsy. The aAbs bind to different GlyR α-subunits and, more rarely, also to the GlyR β-subunit.
View Article and Find Full Text PDFEur J Neurosci
January 2025
Department of Pharmacology, University of Oxford, Oxford, UK.
Cannabinoid receptor 1 (CB1) regulates synaptic transmission through presynaptic receptors in nerve terminals, and its physiological roles are of clinical relevance. The cellular sources and synaptic targets of CB1-expressing terminals in the human cerebral cortex are undefined. We demonstrate a variable laminar pattern of CB1-immunoreactive axons and electron microscopically show that CB1-positive GABAergic terminals make type-2 synapses innervating dendritic shafts (69%), dendritic spines (20%) and somata (11%) in neocortical layers 2-3.
View Article and Find Full Text PDFNPJ Parkinsons Dis
January 2025
Interfaculty Institute of Biochemistry, University of Tübingen, Tübingen, Germany.
The dysfunction of dopaminergic (DA) neurons is central to Parkinson's disease. Distinct synaptic vesicle (SV) populations, differing in neurotransmitter content (dopamine vs. glutamate), may vary due to differences in trafficking and exocytosis.
View Article and Find Full Text PDFEur J Neurosci
January 2025
CNC-Center for Neuroscience and Cell Biology, University of Coimbra, Coimbra, Portugal.
In corticostriatal nerve terminals, glutamate release is stimulated by adenosine via A receptors (ARs) and simultaneously inhibited by endocannabinoids via CB receptors (CBRs). We previously identified presynaptic AR-CBR heterotetrameric complexes in corticostriatal nerve terminals. We now explored the possible functional interaction between ARs and CBRs in purified striatal GABAergic nerve terminals (synaptosomes) and compared these findings with those on the release of glutamate.
View Article and Find Full Text PDFJ Cell Sci
January 2025
Sorbonne Université, INSERM, CNRS, Institut de la Vision, F-75012 Paris, France.
Signal transduction downstream of axon guidance molecules is essential to steer developing axons. Second messengers including cAMP are key molecules shared by a multitude of signaling pathways and are required for a wide range of cellular processes including axon pathfinding. Yet, how these signaling molecules achieve specificity for each of their downstream pathways remains elusive.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!